326 related articles for article (PubMed ID: 16756668)
1. Large scale copy number variation (CNV) at 14q12 is associated with the presence of genomic abnormalities in neoplasia.
Braude I; Vukovic B; Prasad M; Marrano P; Turley S; Barber D; Zielenska M; Squire JA
BMC Genomics; 2006 Jun; 7():138. PubMed ID: 16756668
[TBL] [Abstract][Full Text] [Related]
2. High-resolution analysis of acquired genomic imbalances in bone marrow samples from chronic myeloid leukemia patients by use of multiple short DNA probes.
Reid AG; Tarpey PS; Nacheva EP
Genes Chromosomes Cancer; 2003 Jul; 37(3):282-90. PubMed ID: 12759926
[TBL] [Abstract][Full Text] [Related]
3. Copy number variations associated with idiopathic autism identified by whole-genome microarray-based comparative genomic hybridization.
Cho SC; Yim SH; Yoo HK; Kim MY; Jung GY; Shin GW; Kim BN; Hwang JW; Kang JJ; Kim TM; Chung YJ
Psychiatr Genet; 2009 Aug; 19(4):177-85. PubMed ID: 19407672
[TBL] [Abstract][Full Text] [Related]
4. Genetic predisposition in degenerative lumbar scoliosis due to the copy number variation.
Shin JH; Ha KY; Jung SH; Chung YJ
Spine (Phila Pa 1976); 2011 Oct; 36(21):1782-93. PubMed ID: 21587107
[TBL] [Abstract][Full Text] [Related]
5. Genomic deletions on other chromosomes involved in variant t(9;22) chronic myeloid leukemia cases.
Albano F; Specchia G; Anelli L; Zagaria A; Storlazzi CT; Buquicchio C; Roberti MG; Liso V; Rocchi M
Genes Chromosomes Cancer; 2003 Apr; 36(4):353-60. PubMed ID: 12619159
[TBL] [Abstract][Full Text] [Related]
6. Quantitative PCR identifies a minimal deleted region of 120 kb extending from the Philadelphia chromosome ABL translocation breakpoint in chronic myeloid leukemia with poor outcome.
Kolomietz E; Marrano P; Yee K; Thai B; Braude I; Kolomietz A; Chun K; Minkin S; Kamel-Reid S; Minden M; Squire JA
Leukemia; 2003 Jul; 17(7):1313-23. PubMed ID: 12835719
[TBL] [Abstract][Full Text] [Related]
7. No significance of derivative chromosome 9 deletion on the clearance kinetics of BCR/ABL fusion transcripts, cytogenetic or molecular response, loss of response, or treatment failure to imatinib mesylate therapy for chronic myeloid leukemia.
Kim DH; Popradi G; Sriharsha L; Kamel-Reid S; Chang H; Messner HA; Lipton JH
Cancer; 2008 Aug; 113(4):772-81. PubMed ID: 18543309
[TBL] [Abstract][Full Text] [Related]
8. Unique secondary chromosomal abnormalities are frequently found in the chronic phase of chronic myeloid leukemia in southern Vietnam.
Phan TX; Hoang AV; Huynh VM; Nguyen KT; Nguyen TB; Huynh N; Pham QT; Tran VB; Tran VB; Tokunaga K; Sato Y
Cancer Genet Cytogenet; 2006 Jul; 168(1):59-68. PubMed ID: 16772122
[TBL] [Abstract][Full Text] [Related]
9. The negative prognostic impact of derivative 9 deletions in patients who received hydroxyurea treatment for chronic myelogenous leukemia in the chronic phase.
Li JY; Xu W; Wu W; Zhu Y; Qiu HR; Zhang R; Zhang SJ; Qian SX
Onkologie; 2008 Nov; 31(11):585-9. PubMed ID: 19145090
[TBL] [Abstract][Full Text] [Related]
10. [Study of deletion of derivative chromosome 9 in patients with Ph+ chronic myeloid leukemia].
Wu W; Xue YQ; Wu YF; Pan JL; Shen J
Zhonghua Xue Ye Xue Za Zhi; 2006 Mar; 27(3):183-6. PubMed ID: 16792921
[TBL] [Abstract][Full Text] [Related]
11. Coexistence of Philadelphia chromosome positive cells with and without der(9) deletion in a patient with chronic myelogenous leukemia.
Xinh PT; Vu HA; Nghia H; Binh NT; Van Be T; Van Binh T; Tokunaga K; Sato Y
Cancer Genet Cytogenet; 2006 Jan; 164(2):122-7. PubMed ID: 16434314
[TBL] [Abstract][Full Text] [Related]
12. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.
Phan CL; Megat Baharuddin PJ; Chin LP; Zakaria Z; Yegappan S; Sathar J; Tan SM; Purushothaman V; Chang KM
Cancer Genet Cytogenet; 2008 Jan; 180(1):60-4. PubMed ID: 18068536
[TBL] [Abstract][Full Text] [Related]
13. Genomic segmental duplications on the basis of the t(9;22) rearrangement in chronic myeloid leukemia.
Albano F; Anelli L; Zagaria A; Coccaro N; D'Addabbo P; Liso V; Rocchi M; Specchia G
Oncogene; 2010 Apr; 29(17):2509-16. PubMed ID: 20101201
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of rare copy number variations in epilepsy: a case-control survey using microarray-based comparative genomic hybridization.
Striano P; Coppola A; Paravidino R; Malacarne M; Gimelli S; Robbiano A; Traverso M; Pezzella M; Belcastro V; Bianchi A; Elia M; Falace A; Gazzerro E; Ferlazzo E; Freri E; Galasso R; Gobbi G; Molinatto C; Cavani S; Zuffardi O; Striano S; Ferrero GB; Silengo M; Cavaliere ML; Benelli M; Magi A; Piccione M; Dagna Bricarelli F; Coviello DA; Fichera M; Minetti C; Zara F
Arch Neurol; 2012 Mar; 69(3):322-30. PubMed ID: 22083797
[TBL] [Abstract][Full Text] [Related]
15. A method for accurate detection of genomic microdeletions using real-time quantitative PCR.
Weksberg R; Hughes S; Moldovan L; Bassett AS; Chow EW; Squire JA
BMC Genomics; 2005 Dec; 6():180. PubMed ID: 16351727
[TBL] [Abstract][Full Text] [Related]
16. Molecular cytogenetic characterization of deletions on der(9) in chronic myelocytic leukemia.
Zagaria A; Anelli L; Albano F; Vicari L; Schiavone EM; Annunziata M; Pane F; Liso V; Rocchi M; Specchia G
Cancer Genet Cytogenet; 2006 Jun; 167(2):97-102. PubMed ID: 16737907
[TBL] [Abstract][Full Text] [Related]
17. Acquired genomic copy number changes in CML patients with the Philadelphia chromosome (Ph+).
Lu X; Wang X; Kim Y; Zhang R; Li S; Lee JY
Cancer Genet; 2012 Oct; 205(10):513-8. PubMed ID: 23036696
[TBL] [Abstract][Full Text] [Related]
18. Copy number variation in regions flanked (or unflanked) by duplicons among patients with developmental delay and/or congenital malformations; detection of reciprocal and partial Williams-Beuren duplications.
Kriek M; White SJ; Szuhai K; Knijnenburg J; van Ommen GJ; den Dunnen JT; Breuning MH
Eur J Hum Genet; 2006 Feb; 14(2):180-9. PubMed ID: 16391556
[TBL] [Abstract][Full Text] [Related]
19. Genomic imbalances in CML blast crisis: 8q24.12-q24.13 segment identified as a common region of over-representation.
Gribble SM; Reid AG; Roberts I; Grace C; Green AR; Nacheva EP
Genes Chromosomes Cancer; 2003 Aug; 37(4):346-58. PubMed ID: 12800146
[TBL] [Abstract][Full Text] [Related]
20. Cryptic and partial deletions of PRDM16 and RUNX1 without t(1;21)(p36;q22) and/or RUNX1-PRDM16 fusion in a case of progressive chronic myeloid leukemia: a complex chromosomal rearrangement of underestimated frequency in disease progression?
Deluche L; Joha S; Corm S; Daudignon A; Geffroy S; Quief S; Villenet C; Kerckaert JP; Laï JL; Preudhomme C; Roche-Lestienne C
Genes Chromosomes Cancer; 2008 Dec; 47(12):1110-7. PubMed ID: 18767145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
